333 related articles for article (PubMed ID: 28821461)
1. Cutaneous vaccination with coated microneedles prevents development of airway allergy.
Shakya AK; Lee CH; Gill HS
J Control Release; 2017 Nov; 265():75-82. PubMed ID: 28821461
[TBL] [Abstract][Full Text] [Related]
2. Microneedle-Mediated Allergen-Specific Immunotherapy for the Treatment of Airway Allergy in Mice.
Shakya AK; Lee CH; Gill HS
Mol Pharm; 2020 Aug; 17(8):3033-3042. PubMed ID: 32643940
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of microneedle-based cutaneous immunization with other conventional routes to assess feasibility of microneedles for allergy immunotherapy.
Shakya AK; Gill HS
Vaccine; 2015 Aug; 33(33):4060-4. PubMed ID: 26092307
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Th1/Th2 Bias of STING Agonists Coated on Microneedles for Possible Use in Skin Allergen Immunotherapy.
Shakya AK; Lee CH; Uddin MJ; Gill HS
Mol Pharm; 2018 Nov; 15(11):5437-5443. PubMed ID: 30299105
[TBL] [Abstract][Full Text] [Related]
5. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
[TBL] [Abstract][Full Text] [Related]
6. Microneedles coated with peanut allergen enable desensitization of peanut sensitized mice.
Shakya AK; Ingrole RSJ; Joshi G; Uddin MJ; Anvari S; Davis CM; Gill HS
J Control Release; 2019 Nov; 314():38-47. PubMed ID: 31626861
[TBL] [Abstract][Full Text] [Related]
7. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice.
Huang CF; Wu TC; Chu YH; Hwang KS; Wang CC; Peng HJ
Scand J Immunol; 2008 Nov; 68(5):502-10. PubMed ID: 18822109
[TBL] [Abstract][Full Text] [Related]
8. A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy.
Schülke S; Burggraf M; Waibler Z; Wangorsch A; Wolfheimer S; Kalinke U; Vieths S; Toda M; Scheurer S
J Allergy Clin Immunol; 2011 Dec; 128(6):1340-1348.e12. PubMed ID: 21872305
[TBL] [Abstract][Full Text] [Related]
9. Sustained antigens delivery using composite microneedles for effective epicutaneous immunotherapy.
Zhang E; Zeng B; Song R; Yao L; Che H
Drug Deliv Transl Res; 2023 Jun; 13(6):1828-1841. PubMed ID: 36964440
[TBL] [Abstract][Full Text] [Related]
10. Phenotype analyses of IL-10-producing Foxp3
Matsuda M; Morie Y; Oze H; Doi K; Tsutsumi T; Hamaguchi J; Inaba M; Nabe T
Int Immunopharmacol; 2018 Aug; 61():297-305. PubMed ID: 29909233
[TBL] [Abstract][Full Text] [Related]
11. Laser-facilitated epicutaneous immunotherapy to IgE-mediated allergy.
Kumar MNK; Zhou C; Wu MX
J Control Release; 2016 Aug; 235():82-90. PubMed ID: 27235977
[TBL] [Abstract][Full Text] [Related]
12. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
14. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
[TBL] [Abstract][Full Text] [Related]
15. Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy.
Yasuda T; Ura T; Taniguchi M; Yoshida H
PLoS One; 2016; 11(12):e0167952. PubMed ID: 27973543
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
[TBL] [Abstract][Full Text] [Related]
17. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
[TBL] [Abstract][Full Text] [Related]
18. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design.
Chen MC; Lai KY; Ling MH; Lin CW
Acta Biomater; 2018 Jan; 65():66-75. PubMed ID: 29109028
[TBL] [Abstract][Full Text] [Related]
19. Enhanced efficacy of sublingual immunotherapy by liposome-mediated delivery of allergen.
Aliu H; Rask C; Brimnes J; Andresen TL
Int J Nanomedicine; 2017; 12():8377-8388. PubMed ID: 29200850
[TBL] [Abstract][Full Text] [Related]
20. Micro-fractional epidermal powder delivery for improved skin vaccination.
Chen X; Kositratna G; Zhou C; Manstein D; Wu MX
J Control Release; 2014 Oct; 192():310-6. PubMed ID: 25135790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]